Yokoyama H, et al. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan renal biopsy registry (J-RBR). Clin Exp Nephrol. 2015;19(3):496–505.

Article  PubMed  Google Scholar 

Meyrier A, Niaudet P. Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int. 2018;94(5):861–9.

Article  PubMed  Google Scholar 

Waldman M, et al. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol. 2007;2(3):445–53.

Article  CAS  PubMed  Google Scholar 

Iseki K, et al. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63(4):1468–74.

Article  PubMed  Google Scholar 

Raina R, et al. An update on LDL apheresis for nephrotic syndrome. Pediatr Nephrol. 2019;34(10):1655–69.

Article  PubMed  Google Scholar 

Muso E. Beneficial effect of LDL-apheresis in refractory nephrotic syndrome. Clin Exp Nephrol. 2014;18(2):286–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bohman SO, et al. Foot process fusion and glomerular filtration rate in minimal change nephrotic syndrome. Kidney Int. 1984;25(4):696–700.

Article  CAS  PubMed  Google Scholar 

Hill GS. Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens. 2008;17(3):266–70.

Article  PubMed  Google Scholar 

Meyrier A. Nephrosclerosis: update on a centenarian. Nephrol Dial Transpl. 2015;30(11):1833–41.

Article  Google Scholar 

Wolf SC, et al. Endothelin-1 and endothelin-3 levels in different types of glomerulonephritis. J Cardiovasc Pharmacol. 1998;31(Suppl 1):S482–5.

Article  CAS  PubMed  Google Scholar 

Guan Z, Inscho EW. Endothelin and the renal vasculature. Contrib Nephrol. 2011;172:35–49.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen CL, et al. Increased endothelin 1 expression in adult-onset minimal change nephropathy with acute renal failure. Am J Kidney Dis. 2005;45(5):818–25.

Article  CAS  PubMed  Google Scholar 

Nakamura T, et al. Effect of low-density lipoprotein apheresis on plasma endothelin-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans. J Diabetes Complic. 2003;17(6):349–54.

Article  Google Scholar 

Muso E, et al. Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS study. Clin Exp Nephrol. 2015;19(3):379–86.

Article  CAS  PubMed  Google Scholar 

Muso E, et al. A Prospective observational survey on the long-term effect of ldl apheresis on drug-resistant nephrotic syndrome. Nephron Extr. 2015;5(2):58–66.

Article  Google Scholar 

Muso E, et al. Favorable therapeutic efficacy of low-density lipoprotein apheresis for nephrotic syndrome with impaired renal function. Ther Apher Dial. 2022;26(1):220–8.

Article  CAS  PubMed  Google Scholar 

Donadio JV Jr. Treatment of glomerulonephritis in the elderly. Am J Kidney Dis. 1990;16(4):307–11.

Article  PubMed  Google Scholar 

Moorhead JF, et al. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet. 1982;2(8311):1309–11.

Article  CAS  PubMed  Google Scholar 

Muso E, et al. Updated evidence of beneficial effect of LDL apheresis for refractory nephrotic syndrome due to a variety of causative diseases for nationwide and global approval. Ther Apher Dial. 2023;27(6):987–99.

Article  PubMed  Google Scholar 

Heigl F, et al. Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany. Atheroscler Suppl. 2015;18:154–62.

Article  PubMed  Google Scholar 

Kobayashi S. Applications of LDL-apheresis in nephrology. Clin Exp Nephrol. 2008;12(1):9–15.

Article  CAS  PubMed  Google Scholar 

Sato E, et al. LDL-apheresis contributes to survival extension and renal function maintenance of severe diabetic nephropathy patients: a retrospective analysis. Diabetes Res Clin Pract. 2014;106(2):241–6.

Article  PubMed  Google Scholar 

Nakatani S, et al. The efficacy of low-density lipoprotein apheresis in a patient with drug-resistant minimal change nephrotic syndrome: a case report and a review of the literature. Nephrology (Carlton). 2018;23(6):603–4.

Article  PubMed  Google Scholar 

Nishizono R, et al. Concurrent minimal change nephrotic syndrome and type 1 diabetes mellitus in an adult Japanese woman: a case report. BMC Nephrol. 2020;21(1):410.

Article  PubMed  PubMed Central  Google Scholar 

Terada K, et al. Low-density lipoprotein apheresis in patients with acute kidney injury due to minimal change disease requiring acute renal replacement therapy. Int J Nephrol Renovasc Dis. 2020;13:157–62.

Article  PubMed  PubMed Central  Google Scholar 

Suzuki H, et al. Rituximab-resistant nephrotic syndrome with successful induction of remission by low-density lipoprotein apheresis. Ther Apher Dial. 2017;21(3):295–6.

Article  PubMed  Google Scholar 

Maas RJ, et al. The clinical course of minimal change nephrotic syndrome with onset in adulthood or late adolescence: a case series. Am J Kidney Dis. 2017;69(5):637–46.

Article  PubMed  Google Scholar